3M ($MMM) announced the launch of its Tegaderm CHG intravenous port dressing, saying the device will help oncology patients receive injections comfortably and ward ...
ORLANDO, Fla.--(BUSINESS WIRE)--3M Critical and Chronic Care Solutions today announces the launch of its new 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing, designed for patients with ...
Central line insertion sites are a potential route of catheter-related infection, and disruption of catheter insertion-site dressings might be a factor in the risk for infection. Dressing disruption ...
In our hospital, patients treated with high-dose chemo/radiotherapy (HDC) regimens followed by bone marrow transplantation (BMT) are fitted with a central venous catheter which is usually inserted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results